Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mazor Robotics, originally founded as Mazor Surgical Technologies, is a medical device company specializing in robotic guidance systems for spinal and brain surgeries. The company's core technology, including the Renaissance and Mazor X systems, enables surgeons to perform complex procedures with increased precision and safety through advanced 3D planning and robotic assistance. These systems are designed to improve the accuracy of implant placement, reduce surgical complications, and minimize patient exposure to radiation. In 2018, Mazor was acquired by Medtronic for approximately $1.64 billion, leading to the integration of its robotic platforms into Medtronic's broader restorative therapies portfolio. The acquisition solidified Mazor's technology as a cornerstone of the modern robotic-assisted spine surgery market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mazor Surgical Technologies.